Smallpox vaccine extends life in cancer trial
(Reuters) - A genetically engineered smallpox vaccine reduced the risk of death for patients with advanced liver cancer by nearly 60 percent in a mid-stage study, prompting the launch of a later-stage...
View ArticleGender differences in liver cancer risk explained
Men are four times more likely to develop liver cancer than women, a difference attributed to the sex hormones androgen and estrogen, but the molecular mechanisms by which estrogens prevent -- and...
View ArticleThree 'targeted' cancer drugs raise risk of fatal side effects
Treatment with three relatively new ‘targeted’ cancer drugs has been linked to a slightly elevated chance of fatal side effects, according to a new analysis led by scientists at Dana-Farber Cancer...
View ArticleCompound that rapidly kills liver cancer discovered
Scientists have identified a compound that rapidly kills hepatocellular carcinoma (HCC) cells, the most common form of liver cancer, while sparing healthy tissue. The compound, Factor Qunolinone...
View Article
